Skip to main content
SRZN
NASDAQ Life Sciences

Surrozen 报告242M全年净亏损,EPS 为-32.37

feedReported by Reuters
Sentiment info
Negative
Importance info
8
Price
$25.24
Mkt Cap
$216.343M
52W Low
$5.9
52W High
$29.595
Market data snapshot near publication time

summarizeSummary

Surrozen, Inc. 报告了一笔巨大的全年净亏损,达到242.026百万美元,相当于每股亏损-32.37美元。该公司还报告了-42.092百万美元的营业收入和45569万美元的营业费用。这些巨大的亏损对于像Surrozen 这样规模的公司来说是非常重要的,引发了人们对其财务健康和现金燃烧率的严重质疑。专业交易者将这些结果视为关键更新,可能影响公司的估值和未来融资前景。投资者现在将密切关注公司的现金储备和任何战略计划以解决这些重大财务支出。

在该公告发布时,SRZN的交易价格为$25.24,交易所为NASDAQ,所属行业为Life Sciences,市值约为$2.2亿。 52周交易区间为$5.90至$29.60。 这则新闻被评估为消极市场情绪,重要性评分为8/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed SRZN - Latest Insights

SRZN
Mar 30, 2026, 6:21 PM EDT
Filing Type: 424B5
Importance Score:
7
SRZN
Mar 25, 2026, 8:02 PM EDT
Filing Type: 4
Importance Score:
8
SRZN
Mar 23, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
9
SRZN
Mar 23, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
SRZN
Mar 23, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
SRZN
Mar 23, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
SRZN
Mar 16, 2026, 7:05 PM EDT
Filing Type: 4
Importance Score:
7
SRZN
Jan 22, 2026, 6:55 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SRZN
Jan 20, 2026, 7:35 PM EST
Filing Type: 4
Importance Score:
7
SRZN
Jan 08, 2026, 5:19 PM EST
Filing Type: 4
Importance Score:
7